Consolidated Health Economic Evaluation Reporting Standards (CHEERS) Statement-Reference-Cited by-同舟云学术

Consolidated Health Economic Evaluation Reporting Standards (CHEERS) Statement

Published:2013-04 Issue:4 Volume:35 Page:356-363
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Husereau Don,Drummond Michael,Petrou Stavros,Carswell Chris,Moher David,Greenberg Dan,Augustovski Federico,Briggs Andrew H.,Mauskopf Josephine,Loder Elizabeth

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference24 articles.

1. Methods for the Economic Evaluation of Health Care Programmes;Drummond,2005

2. Key principles for the improved conduct of health technology assessments for resource allocation decisions;Drummond;Int J Technol Assess Health Care,2008

3. Pharmacoeconomic analyses;Rennie;JAMA,2000

4. The quality of reporting in published cost-utility analyses, 1976–1997;Neumann;Ann Intern Med,2000

5. Quality of abstracts of papers reporting original cost-effectiveness analyses;Rosen;Med Decis Making,2005

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unwarranted variation in perioperative pain management for pediatric anterior cruciate ligament reconstruction: a call to improve the quality of quality improvement;Regional Anesthesia & Pain Medicine;2024-06-25

2. A cost-effectiveness analysis of a housing and recovery program for people with severe and persistent mental illnesses and precarious housing;Journal of Social Distress and Homelessness;2024-05-16

3. Seeking outcomes under tight budgets: A case for health impact bonds in Post‐COVID times;The International Journal of Health Planning and Management;2023-11-04

4. Economic evaluation of web‐based guided self‐help cognitive behavioral therapy‐enhanced for binge‐eating disorder compared to a waiting list: A randomized controlled trial;International Journal of Eating Disorders;2023-06-12

5. Cost-effectiveness analysis of serplulimab in combination with cisplatin plus 5-fluorouracil chemotherapy compared to cisplatin plus 5-fluorouracil chemotherapy as first-line treatment for advanced or metastatic esophageal squamous cell carcinoma in China;Therapeutic Advances in Medical Oncology;2023-01